- Trials with a EudraCT protocol (75)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
75 result(s) found for: Brain trauma.
Displaying page 1 of 4.
EudraCT Number: 2009-012338-56 | Sponsor Protocol Number: VAS203/II/1/03 | Start Date*: 2009-07-10 | |||||||||||
Sponsor Name:vasopharm GmbH | |||||||||||||
Full Title: AN EXPLORATIVE PHASE IIa STUDY TO ASSESS SAFETY, TOLERABILITY, PHARMACODYNAMICS AND PHARMACOKINETICS OF VAS203 IN PATIENTS WITH MODERATE AND SEVERE TRAUMATIC BRAIN INJURY | |||||||||||||
Medical condition: Moderate and severe traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FR (Completed) ES (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002813-11 | Sponsor Protocol Number: ISRCTN23625128 | Start Date*: 2007-01-02 | |||||||||||
Sponsor Name:Xytis Pharmaceuticals Sàrl | |||||||||||||
Full Title: A phase II randomised, double blind, placebo-controlled, dose finding, safety and tolerability trial of XY2405 as a treatment for traumatic brain injury | |||||||||||||
Medical condition: Moderate to Severe Traumatic Brain Injury | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) CZ (Completed) BE (Completed) EE (Prematurely Ended) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000584-13 | Sponsor Protocol Number: ASSENTE | Start Date*: 2007-05-15 | |||||||||||
Sponsor Name:OSPEDALE MAGGIORE DI MILANO (IRCCS) | |||||||||||||
Full Title: Normothermia in patients with acute cerebral damage | |||||||||||||
Medical condition: Subarachnoid hemorrhage, traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002545-10 | Sponsor Protocol Number: OSU6162Open1309 | Start Date*: 2014-01-08 |
Sponsor Name:A. Carlsson Research AB | ||
Full Title: An open safety study with the monoaminergic stabilizer (-)-OSU6162 in patients with mental fatigue and related vitality and wakefulness disturbances associated with neurologiacal disorders, e g P... | ||
Medical condition: Parkinsons disease Huntingtons disease Multiple scleros Brain trauma Stroke Myalgic encephalomyelitis Narcolepsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005235-22 | Sponsor Protocol Number: ANZIC-RC/RB002 | Start Date*: 2012-01-18 | |||||||||||
Sponsor Name:Monash University | |||||||||||||
Full Title: A randomised, placebo-controlled trial of erythropoietin in ICU patients with traumatic brain injury: Erythropoietin in Traumatic Brain Injury | |||||||||||||
Medical condition: Traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) FR (Ongoing) DE (Ongoing) IE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001409-40 | Sponsor Protocol Number: S334.2.002 | Start Date*: 2009-03-04 | |||||||||||
Sponsor Name:Solvay Pharmaceuticals B.V. | |||||||||||||
Full Title: A Randomized, Double blind, Placebo-Controlled Dose Escalation Study to Investigate the Safety and Pharmacokinetics after Single and Multiple Doses of SLV334 in Sequential Cohorts of Patients with ... | |||||||||||||
Medical condition: Moderate and severe Traumatic Brain Injury (TBI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001909-41 | Sponsor Protocol Number: 5070197 | Start Date*: 2008-04-11 | ||||||||||||||||||||||||||
Sponsor Name:Stepani Bendel | ||||||||||||||||||||||||||||
Full Title: Hydrokortisonihoito elinluovutuspotilailla (HYDRO) | ||||||||||||||||||||||||||||
Medical condition: Tutkittavilla on vakava aivovamma ja/tai lukinkalvonalainen verenvuoto, eikä heitä voida parantaa sairaudestaan. Heitä hoidetaan teho-osastolla mahdollisina elintenluovutuspotilaina. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-004244-37 | Sponsor Protocol Number: 13HH1824 | Start Date*: 2014-02-21 | |||||||||||
Sponsor Name:Imperial College London | Imperial College NHS Healthcare Trust | |||||||||||||
Full Title: The control of brain networks after traumatic brain injury: a neuroimaging and neuropsychological study of dopamine and cognition | |||||||||||||
Medical condition: Traumatic Brain Injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005707-42 | Sponsor Protocol Number: A090624 | Start Date*: 2007-07-23 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | |||||||||||||
Full Title: A single centre phase II study of Interleukin 1 receptor antagonist in the treatment of severe Traumatic Brain Injury | |||||||||||||
Medical condition: Severe Traumatic Brain Injury | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018283-16 | Sponsor Protocol Number: BHR-100-301 | Start Date*: 2010-09-24 | |||||||||||
Sponsor Name:BHR Pharma, LLC | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients with Severe Traumatic Brain Injury | |||||||||||||
Medical condition: Severe traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) HU (Completed) GB (Completed) CZ (Completed) NL (Completed) AT (Completed) DE (Completed) ES (Completed) IT (Completed) FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003382-38 | Sponsor Protocol Number: FSNANO05012022 | Start Date*: 2023-01-12 | |||||||||||
Sponsor Name:FSNANO05012022 | |||||||||||||
Full Title: Efficacy and safety of Cerebrolysin for neurorecovery after moderate-severe traumatic brain injury | |||||||||||||
Medical condition: Moderate-severe traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: RO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006694-39 | Sponsor Protocol Number: ASF-CP02-001 | Start Date*: 2022-07-08 | ||||||||||||||||
Sponsor Name:Lantmännen Medical AB | ||||||||||||||||||
Full Title: An open-label, historical cohort control study to evaluate the safety and tolerability of AF-16 in patients with cerebral oedema caused by traumatic brain injury (TBI) | ||||||||||||||||||
Medical condition: Cerebral oedema caused by traumatic brain injury (TBI) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000925-60 | Sponsor Protocol Number: R1/11 | Start Date*: 2011-10-18 |
Sponsor Name:Kungälv Hospital | ||
Full Title: Effect of treatment with methylphenidate on mental fatigue (“brain fatigue”) and pain on persons who have suffered a traumatic brain injury or whip lash injury – a pilot study. | ||
Medical condition: Mental fatigue after traumatic brain injury or whip-lash injury | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003391-40 | Sponsor Protocol Number: 2020-KEP-456 | Start Date*: 2020-12-17 | |||||||||||
Sponsor Name:London School of Hygiene and Tropical Medicine | |||||||||||||
Full Title: Intramuscular tranexamic acid for the treatment of symptomatic mild traumatic brain injury in older adults: a randomised, double-blind, placebo-controlled trial. | |||||||||||||
Medical condition: Mild traumatic brain injury. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003669-14 | Sponsor Protocol Number: ISRCTN15088122 | Start Date*: 2012-12-03 | |||||||||||
Sponsor Name:London School Of Hygiene and Tropical Medicine | |||||||||||||
Full Title: Tranexamic Acid for the treatment of significant traumatic brain injury: an international, randomised, double blind, placebo controlled trial. | |||||||||||||
Medical condition: Traumatic Brain Injury | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) GB (Completed) IT (Completed) IE (Completed) SI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000140-58 | Sponsor Protocol Number: NL7255100000 | Start Date*: 2020-07-23 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Complement Inhibition: Attacking the Overshooting Inflammation @fter Traumatic Brain Injury - A phase II trial on the safety and efficacy of C1 esterase inhibitor Cinryze for the acute management o... | |||||||||||||
Medical condition: Severe traumatic Brain Injury (TBI) with GCS < 13 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006518-13 | Sponsor Protocol Number: LOC/06-06 | Start Date*: 2007-05-03 | |||||||||||
Sponsor Name:Centre Hospitalier Universitaire Rennes | |||||||||||||
Full Title: Etude prospective, randomisée, en double aveugle, comparant l’efficacité du lévétiracétam à un placebo sur la prévention des crises d’épilepsie précoces et tardives chez les patients présentant un ... | |||||||||||||
Medical condition: Prévention des crises d'épilepsie précoces et tardives chez des patients présentant un traumatisme crânien sévère | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002433-15 | Sponsor Protocol Number: RS200511 | Start Date*: 2021-02-15 | ||||||||||||||||||||||||||
Sponsor Name:Region Skåne | ||||||||||||||||||||||||||||
Full Title: Positron emission tomography (PET) of patients with brain injury and athletes with concussion symptoms - Descriptive study of the tau tracer 18F-RO6958948 | ||||||||||||||||||||||||||||
Medical condition: Traumatic brain injury (TBI), cerebral haemorrhage (ICH), subarachnoid haemorrhage (SAH) and cerebral commotio. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SE (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001650-29 | Sponsor Protocol Number: MF02/11 | Start Date*: 2011-12-19 |
Sponsor Name:A. Carlsson Research AB | ||
Full Title: TREATMENT OF MENTAL FATIGUE ("BRAIN FATIGUE") WITH THE DOPAMINERGIC STABILIZER OSU6162 AFTER STROKE AND MILD/MODERATE TRAUMATIC BRAIN INJURY– INCREASE OF PATIENT NUMBER | ||
Medical condition: Mental fatigue after stroke or mild to moderate head trauma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003716-12 | Sponsor Protocol Number: RHNIA-001-2021 | Start Date*: 2022-08-24 | ||||||||||||||||||||||||||
Sponsor Name:Rigshospitalet | ||||||||||||||||||||||||||||
Full Title: S-ketamine for cortical spreading depolarisation in patients with severe acute brain injury | ||||||||||||||||||||||||||||
Medical condition: Severe acute brain injury caused by aneurysmal subarachnoid hemorrhage, spontaneous intracerebral hemorrhage or traumatic brain injury. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
